In other studies, it was shown that nuclear accumulation of S6K1 correlated with the reduced tamoxifen effect in breast cancer patients, while cytoplasmic localization of S6K1 was associated with better prognosis for the patients (Bostneret al., 2015). Here, RPS6KB1 is linked to breast cancer.